Search earnings tickers

MRNA

2026Q2BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-07-31 · Fiscal end 2026-06-30 · Features as of 2026-07-30

← Earnings history

Street

Consensus EPS-1.97

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move4.6%

IV front—

P/C full—

P/C front—

Features as of2026-07-30

Run-up

Close—

Ret 5d+1.6%

Ret 10d-8.3%

Ret 20d-20.1%

Ret 30d+4.5%

Print

Actual EPS

-1.97—

Estimated EPS-1.97

Actual revenue

145.0M

Surprise %0.0%

Beat / miss—

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction-5.2%

Implied vs actual

Implied 4.6%Actual 0.1%

Gap reaction-0.1%

Day result-5.4%

Next-day upNo

Realized / IV0.03×

Post tape

Post 5d+7.9%

Post 10d+15.5%

Post volume7.8M

Vol ×10d1.68×

Vol ×20d1.20×

Post range8.3%